Ark Solutions Inc (KOSDAQ:203690)

Market Cap	68.91B
Revenue (ttm)	32.66B
Net Income (ttm)	-22.97B
Shares Out	15.57M
EPS (ttm)	-1,889.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,859
Average Volume	9,472
Open	4,580.00
Previous Close	4,500.00
Day's Range	4,300.00 - 4,580.00
52-Week Range	3,815.00 - 14,040.00
Beta	0.53
RSI	28.88
Earnings Date	Mar 21, 2025

About Ark Solutions

Ark Solutions Inc. engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally. It operates through Life and Health Business and Exosome Business divisions. The company offers products using stem cells. The company also provides cosmetics for hospitals and clinics, such as AAPE, a products containing high concentration human cell culture medium that helps improve the skin and scalp; Cytovesicle, a product that contains cytocore and high-concentration human stem cell culture medium that re...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Employees: 55
• Stock Exchange: KOSDAQ
• Ticker Symbol: 203690

Financial Performance

In 2023, Ark Solutions's revenue was 37.25 billion, an increase of 40.18% compared to the previous year's 26.58 billion. Losses were -24.37 billion, 354.1% more than in 2022.